Issue 1-83, 2018

Possibilities of Placentary Medicine in Restoration Treatment

View article (Download PDF file)



Download XML file

1 Maksimov V.A., 2 Karimova I.M.

1 GBOU DPO "Russian Medical Academy of Postgraduate Continuous Education" of the Ministry of Health of Russia, Moscow, Russia
2 FGBOU at the Moscow State Medical University "Moscow State Medical and Dental University". A.I. Evdokimova, Ministry of Health of Russia, Moscow, Russia


ABSTRACT

The international data on influence of placentary therapy on recovery processes are provided in a human body in this article.Mechanisms of regeneration of bodies and fabrics, and also recovery processes of metabolism of a human body on the basis ofthe 80th summer experience of use of placentary medicines and in particular a hydrolyzate of a placenta of the person Layennek(Japan Bioproducts Industry, Japan) are stated. From the point of view of evidential medicine the multifunctional pharmacologicalproperties of placentary medicines which are defined by their multicomponent and native structure reveal.


KEYWORDS: biomedicine, recovery medicine, evidential medicine, extract of a placenta of the person, active longevity, quality of life, placenta hydrolyzate, Layennek


References:

  1. VP Filatov, Ershkovich I.G. Therapeutic implantation of the canned placenta in glaucoma: Scientific materials of the Ukrainian Institute of Experimental Ophthalmology.1939. 250s;
  2. OA Gromova, I.Yu.Torshin, E.A. Dibrova, I.M.Karimova, A.V. Gilels, E.V. Kustova; World experience in the use of drugs prepared from the human placenta: the results of clinical and experimental studies ", Journal of Plastic Surgery and Cosmetology, 3: 1-12, 2011;
  3. IV Kuznetsova, TV Sheveleva, OS Pobedinskaya, Yu.B. Uspenskaya, AV Gilels, Use of the human placenta for the purpose of treatment for insufficient proliferation of the endometrium. Gynecology, 2013, C44-48;
  4. A.V. Rassokhin. Tissue placental therapy. St. Petersburg. ELBI-SPb.2014, C10;
  5. ANIlnitsky, VAMaksimov, IMKarimova, NMPozdnyakova. Anti-aging medicine: issues of hepatology. A manual for doctors. Moscow. Publishing house Adamant. 2016, 37c;
  6. OS. Glazachev, E.N. Dudnik, E.E. Zagajnaya, Journal of Neurology and Psychiatry, Moscow, Russia 1, 2017;
  7. Ueda H., Injections of the placenta drug had superiority over placebo in patients with chronic liver disease in a double-blind, cross-over, comparative study. Kanzo.1974, C162-171;
  8. Mi Chi Kon, The effect of human placenta extract on the health status of elderly Koreans. Evidence-BasedComplementaryandAlternativeMedicine, 2012, C1-5;
  9. H. Simokobe. Treatment with placental extract of a non-alcoholic steatohepatitis person who does not respond to intervention through lifestyle correction. Experimental study. HepatologyResearch, 2014, C1034-1040;
  10. OA Gromova, I.Yu. Torshin, A.Yu.Volkov, SNSmarygin, OA Nazarenko. The drug Laennek: the elementary composition and pharmacological action. Injection methods in cosmetology 2010. №4, С7-11 .;
  11. OA Gromova, AV Gilels, I.Yu. Torshin, A. Yu. Volkov, IV Tomilova Peptide composition of preparations from the human placenta. Laennek and molecular mechanisms of its effect on the human body. Aesthetic medicine 2010 №4, С7-11;
  12. OA Gromova, AV Gilels, I.Yu. Torshin, A.Yu. Volkov, IV Tomilova. An experimental analysis of the vitamin composition of the preparation Laennek. Journal of Aesthetic Medicine, 2013№3, С5-7;
  13. M. Imavari. What is placental hydrolyzate ?, 2017, C15;
  14. M. Imavari. What is placental hydrolyzate ?, 2017, C17;
  15. ON Minushkin, LV Maslovskiy, VA Maksimov, LB Lazebnik, RG Sayfutdinov, AI Paltsev, GA Elizavetin, EA Dibrova, OA Gromova, TB Topchiy. Laennek is a new hepatoprotective drug for the treatment of steatohepatitis of various etiologies. Kremlin medicine, 2017, C65-67;
  16. ON Minushkin, LVMaslovsky, GAAlizavetina, AVKalinin, TKDubovaya, and EADibrova. Application of the drug Laennek in gastroenterological practice. Separate edition, C8-14;
  17. Mi Chi Kon, The effect of human placenta extract on the symptoms of menopause, fatigue and risk factors for the development of cardiovascular disease in Korean middle-aged women. The Journalof the North American Menopause Society. 2008, C296-303;
  18. TszinYongChoy, Efficacy and safety of human placental extract application for alcoholic and non-alcoholic steatohepatitis: Open, randomized, comparative study. Pharm. Bull.2014, C1853-1859.



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©2025


This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.